January 17, 2025 LAS VEGAS — New research findings from Visioneering Technologies Inc. (VTI) are highlighting another benefit of NaturalVue Multifocal contact...
January 17, 2025 LAS VEGAS — Visioneering Technologies Inc. (VTI) has shared the preliminary two-year findings from its ongoing PROTECT (PROgressive Myopia...
sponsored content January 2, 2025 By Brett O’Connor, OD, FAAO With myopia reaching epidemic proportions in countries around the world, eye care...
November 27, 2024 LONDON – Visioneering Technologies, Inc. was presented with The Contact Lens Award of 2024 by The Optician Awards in...
sponsored content October 15, 2024 SANYA, Hainan Island, China – Dr. Ashley Tuan, OD, PhD, the Chief Medical Officer of Visioneering Technologies,...
October 7, 2024 HAINAN ISLAND, China, and DALLAS, Texas — Visioneering Technologies Inc. (VTI) has presented the latest data from its PROTECT...
September 8, 2023 CHICAGO — Visioneering Technologies Inc. completed a six-year clinical trial for its NaturalVue Multifocal (MF) contact lenses, and now,...
December 7, 2022 ATLANTA — Visioneering Technologies Inc.’s PROTECT (PROgressive Myopia Treatment Evaluation for NaturalVue Multifocal Contact Lens Trial) study has officially reached 100% participant enrollment....
July 13, 2022 ATLANTA – Medical device company and producer of NaturalVue Multifocal 1 Day Contact Lenses, Visioneering Technologies, Inc (ASX:VTI) announced...
July 8, 2022 ATLANTA — Findings from Visioneering Technologies Inc.’s (VTI) six-year myopia management clinical trial were published in the Clinical Ophthalmology journal. The study...
sponsored content April 1, 2022 We believe that for myopia management, there needs to be a lot of tools in [the practitioner’s]...
sponsored content March 15, 2022 Visioneering Technologies Inc. (VTI) has launched an international clinical trial that will test the efficacy of its...